Results 201 to 210 of about 186,638 (392)

A review of isotretinoin in the treatment of frontal fibrosing alopecia [PDF]

open access: hybrid
Amirhossein Shahpar   +3 more
openalex   +1 more source

Impact of Sequential Ramucirumab Plus Docetaxel After PD‐1 Inhibitors on Anti‐PD‐1 Antibody‐Bound T‐Cell Dynamics and Clinical Outcomes

open access: yesCancer Science, EarlyView.
Ramucirumab (RAM) plus docetaxel (DOC) after PD‐1 inhibitors showed clinical activity, with responders exhibiting maintained anti–PD‐1 (IgG4+)‐bound CD8+ T cells and decreased IgG4+ Tregs. A sequential strategy of administering RAM plus DOC during persistent anti–PD‐1 antibody binding may be beneficial in patients with advanced non‐small cell lung ...
Kinnosuke Matsumoto   +20 more
wiley   +1 more source

Moth-Eaten Pattern of Alopecia in Lichen Planopilaris. [PDF]

open access: yesClin Case Rep
Jaiswal S   +3 more
europepmc   +1 more source

The role of vitamin D receptor signaling in hair follicle health and alopecia: Current understanding and therapeutic implications. [PDF]

open access: yesJ Cell Commun Signal
The vitamin D receptor (VDR) regulates hair follicle biology through ligand‐dependent and ligand‐independent mechanisms by heterodimerizing with retinoid X receptor, recruiting coactivator complexes, and activating target genes including Wnt inhibitors, hair keratins, and cell cycle regulators.
Guan L   +8 more
europepmc   +2 more sources

Needs Assessment to Enhance Knowledge of People in Puerto Rico Living with Alopecia Areata.

open access: green, 2021
Rafael J Rivera-Ortiz   +3 more
openalex   +1 more source

Brentuximab vedotin and radiotherapy for CD30‐positive cutaneous T‐cell lymphoma – a retrospective multicenter analysis

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives While brentuximab vedotin (BV) and radiotherapy (RTx) are established treatment options for CD30‐positive cutaneous T‐cell lymphoma (CTCL), data on their simultaneous or sequential use regarding efficacy and tolerability remain scarce.
Patrick Schummer   +10 more
wiley   +1 more source

Quality of life in patients with scarring and non‐scarring alopecia: An exploratory cross‐sectional study

open access: yesJDDG: Journal der Deutschen Dermatologischen Gesellschaft, EarlyView.
Summary Background and Objectives Hair loss disorders impact quality of life (QoL) far beyond cosmetic issues, with previous studies showing mild to moderate impairment. This study aimed to assess QoL impairment in hair loss patients, comparing scarring and non‐scarring alopecia, and to analyze possibly related influencing factors.
Agathe Franz   +7 more
wiley   +1 more source

Home - About - Disclaimer - Privacy